Browsing by Author "Kesikburun, Serdar"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item Botulinum toxin injection for bruxism associated with brain injury: Case report(Journal Rehab Res & Dev, 2014) Kesikburun, Serdar; Alaca, Rıdvan; Aras, Berke; Tuǧcu, İlknur; Tan, Arif KenanBruxism is involuntary grinding of the teeth and can occur as a complication of brain injury. If untreated, bruxism can lead to severe occlusal trauma. Herein, we present a patient with traumatic brain injury and nocturnal bruxism that was treated with botulinum toxin injection. A 21 yr old male patient with traumatic brain injury from a car accident was admitted to our inpatient rehabilitation unit. He had a history of coma for 2 wk in the intensive care unit. The initial cranial computed tomography scan indicated a superior thalamic hemorrhage. On admission to our department 3 mo postinjury, his mental status was good and he was able to walk without assistance, but he had mild ataxia. He complained about severe teeth grinding at night, which began 2 mo postinjury. Botulinum toxin-A was injected into the masseter muscles (20 U in each muscle) and temporalis muscles (15 U in each muscle) bilaterally. A decrease in bruxism was reported within 3 d. Clinical improvement persisted at assessment 4 mo posttreatment. Botulinum toxin injection can be used as an effective treatment for bruxism associated with brain injury.Item Exacerbation of myasthenia gravis by alendronate(Springer London Ltd, 2014-07-05) Kesikburun, Serdar; Güzelküçük, Ümüt; Alay, Semih; Yavuz, Ferdi; Tan, Arif Kenan; YokMyasthenia gravis is an important indication for the long-term prescription of corticosteroids. We present a patient with myasthenia gravis who had worsening of symptoms associated with the use of alendronate. A 24-year-old patient with myasthenia gravis had been administered oral systemic corticosteroid (deflazacort 40 mg/day) for 3 years in order to control his myasthenic symptoms. One year earlier, his lumbar spine bone mineral density was decreased. He was started on oral calcium/vitamin D3 and alendronate (70-mg tablets once a week) for osteoporosis. He reported an exacerbation of muscle weakness and extreme fatigue on days when he took alendronate. He could not work on these days and has to be on leave. Alendronate was stopped, and he was started on intravenous ibandronate injections given every 3 months. He did not experience muscle weakness and fatigue with ibandronate therapy. Alendronate should be used with caution in patients with myasthenia gravis who have corticosteroid-induced osteoporosis.Item Major perirectal hematoma complicating sacroiliac joint injection(Taylor & Francis Ltd, 2013-04-24) Adıgüzel, Emre; Kesikburun, Serdar; Yaşar, Evren; Taşkaynatan, Mehmet AliBackground: Sacroiliac joint injection is both a way of confirming sacroiliac joint pain and a therapeutic method. Findings: A 40-year-old woman was presumptively diagnosed as having sacroiliac joint dysfunction and we performed a fluoroscopically guided sacroiliac joint injection. Many hours after the procedure, the patient developed severe buttock pain spreading to the posterior aspect of the femur on the left side. A pelvic magnetic resonance imaging revealed a 9 x 4 x 5.5 cm sized hematoma extending from the left obturator to the perirectal region. Conclusions: Because of anatomical variations, the practitioner should be alert to the risk of damaging vascular structures when performing therapeutic injections.Item Metastatic malign melanoma of supraspinatus muscle(Bayçınar Tıbbi Yayıncılık, 2014-03) Kesikburun, Serdar; Uran, Ayça; Aydemir, Koray; Tan, Arif Kenan; YokItem Spinal cord injury in older population in Turkey(Springernature, 2014-05-19) Güzelküçük, Ümüt; Demir, Yasin; Kesikburun, Serdar; Yaşar, Evren; Yılmaz, Bilge; YokStudy design: Retrospective, comparative 4-year study. Objectives: To identify the clinical characteristics unique to older patients with spinal cord injury (SCI). Setting: Turkish Armed Forces Rehabilitation Center, Ankara, Turkey. Methods: The study included 870 consecutive patients with SCI that were divided into two groups according to age. Patients aged >= 60 years at the time of injury constituted the study group, and randomly selected patients aged <60 years that were matched for gender, week of admission and time since injury constituted the control group. Patients' demographic and clinical characteristics were recorded, compared and analyzed. Results: The study group included 73 SCI patients (mean age: 66.98 +/- 6.28 years) and the control group included 75 SCI patients (mean age: 33.93 +/- 10.67 years). Among the 148 patients, 98 (66.2%) were male. The vast majority of lesions were at the thoracic level (47.3%). In the older group, falls were the most frequent etiology (32.9%), simple falls predominated (62.5%). 49.3% of the study group vs 18.6% of the control group had a non-traumatic cause of SCI. Older patients were found to be less likely to have complete injury (27.4 vs 44%, P = 0.035). The most common bladder management method was intermittent catheterization (69.6%) and the number of patients in each group treated with this method did not differ significantly (P>0.05). More patients in the study group had neuropathic pain (50.7 vs 34.7%, P = 0.049) and abnormal urinary ultrasound findings (23.3 vs 9.3%, P = 0.021). Conclusion: Results revealed that older patients with SCI may have different demographic and clinical features compared with younger patients.Item Ultrasound guided block of the saphenous neuroma following use of an AFO in a patient with paraplegia: A case report(Edizioni Minerva Medica, 2014) Kesikburun, Serdar; Omaç, Özlem Köroǧlu; Yaşar, Evren; Yılmaz, Bilge; Tan, Arif KenanThe saphenous nerve is the terminal branch of the femoral nerve and a pure sensory nerve that provide sensation to medial leg. Injury to saphanous nerve following trauma or surgery of the knee can result in formation of a painful neuroma along its distribution. We present a case of saphenous neuroma following use of an ankle-foot orthosis (AFO) in a patient with paraplegia. A 36-year-old patient with paraplegia who was capable of walking independently with his AFO presented to our department with a 3-month history of pain in his left calf. Examination revealed tenderness, paresthesias and positive Tinel sign over the anteromedial aspect of the calf. Ultrasonographic examination of the painful area showed a mass with heterogenous echogenity which was consistent with a saphenous neuroma at the site where fastener band of AFO compressed to skin. We performed a nerve block with steroid and local anesthetic injection under ultrasound guidance to the neuroma. The patient reported pain relief following injection. The use of the AFO may cause a painful saphenous neuroma which is an unusual cause of extremity pain in patients with paraplegia. Ultrasound may be a beneficial diagnostic tool and a guidance for the therapeutic interventions in this condition.